Type I interferons and IL-12: Convergence and cross-regulation among mediators of cellular immunity

European Journal of Immunology

Volumn 31, Issue 7, 2001, Pages 2026-2034

  Byrnes, Adriana A ^a   Xiaojing, M ^a   Cuomo, Peter ^b   Park, Kiwon ^b   Wahl, Larry ^a   Wolf, Stanley F ^c   Zhou, Huanfang ^a   Trinchieri, Giorgio ^b   Karp, Christopher L ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d Genetics Institute   (United States)

Author keywords

IFN ; IFN ; IL 12; Monocyte macrophage; Th1 Th2

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; PROTEIN P40; RECOMBINANT ALPHA INTERFERON; RECOMBINANT BETA INTERFERON; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; BINDING AFFINITY; CELLULAR IMMUNITY; CLEARANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HOST; HUMAN; HUMAN CELL; IMMUNOREGULATION; INJURY; INTERFERON PRODUCTION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; PATHOGENESIS; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; IMMUNITY, CELLULAR; INTERFERON-ALPHA; INTERFERON-BETA; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGES; MONOCYTES; MONOKINES; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RESPONSE ELEMENTS; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0034944385     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200107)31:7<2026::AID-IMMU2026>3.0.CO;2-U     Document Type: Article

References (62)

1. Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and beta subunits of the type I interferon receptor
2. How cells respond to interferons
3. Proinflammatory cytokines and immunity
4. Interferon beta in multiple sclerosis: Is IL-12 suppression the key?
5. Type I interferons (IFN) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFN
6. Type I interferons keep activated T cells alive
7. Induction of bystander T cell proliferation by viruses and type I interferon in vivo
8. Hepatitis, C
9. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
10. Management of multiple sclerosis
11. Viral Hepatitis
12. Immunological aspects of demyelinating diseases
13. Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: An overview of randomized trials
14. Interleukin-12: A cytokine at the interface of inflammation and immunity
15. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection
16. IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononu-clear cells: Selective inhibition of CD40-dependent interleukin-12 secretion
17. Differential induction of IL-12 by IFN-beta and IFN-gamma in human macrophages
18. Type I IFN inhibit human dendritic cell IL-12 production and Th1 cell development
19. IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells
20. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: Relevance to IFN-beta-1b therapeutic effects in multiple sclerosis
21. Two roads diverged: Interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection
22. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2
23. Type I interferons enhance production of IFN-gamma by NK cells
24. Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation
25. Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells
26. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
27. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development
28. Mechanism of suppression of cell-mediated immunity by measles virus
29. + T cells and monocytes
30. Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis
31. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis
32. Selective suppression of IL-12 production by chemoattractants
33. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance
34. Regulation of interleukin-12 by complement receptor 3 signaling
35. C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes
36. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF
37. Prostaglandin-E-2 is a potent inhibitor of human interleukin 12 production
38. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors
39. Positive and negative regulation of interleukin-12 gene expression
40. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site
41. Synergistic regulation of the human interleukin-12 p40 promoter by NFkappaB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages
42. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter
43. A critical role of interferon consensus sequence binding protein (ICSBP) in the activation of IL-12 p40 gene promoter
44. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells
45. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins
46. IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression
47. Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage
48. Suppression of IL-12 transcription in macrophages following Fc gamma receptor ligation
49. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages
50. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II
51. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages
52. IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guerin immunotherapy
53. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells
54. Interleukin-12: Amiss in MS
55. Exacerbations of multiple sclerosis in patients treated with gamma interferon
56. Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C
57. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers
58. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
59. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection
60. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes
61. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alpha
62. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy